Nasdaq · Biotech stocks database

NATR — Nature's Sunshine Products Inc.

NATR (Nature's Sunshine Products Inc.) stock: $13.02, $229.1M market cap, $82.5M cash, $146.6M EV, $265.6M fully diluted market cap. Data from Fully Diluted's biotech stocks database.

Share price

$13.02

Market cap

$229.1M

Cash

$82.5M

Enterprise value

$146.6M

Balance sheet

Cash	$82.5M
Debt	$0.0M
Net cash	$82.5M
Enterprise value	$146.6M
Basic shares	17.6M shares
Fully diluted shares	20.4M shares
Fully diluted market cap	$265.6M
Cash per share	$4.69

Cash figures as of 2026-06-30. Database snapshot: 2026-09-21.

Price history

Loading NATR daily closes…

Loading price history…

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT07447843	Not disclosed	Not yet recruiting	Sponsor	NATR	—	Obesity & Overweight	—

Sponsor-matched active trials from ClinicalTrials.gov (1 as sponsor, 0 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 1 active trials for Nature's Sunshine Products, Inc. on ClinicalTrials.gov

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego